genetic screening

AssureRX

Claremont Creek Ventures portfolio company AssureRx Health raises $11 Million Series B financing

By Claremont Creek Alerts / March 25, 2011 / 0 Comments

– Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics – CINCINNATI, March 25, 2011 – AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric […]

Read More

Gene Security Network Completes Funding to Expand Into New DNA Testing Markets

By Claremont Creek Alerts / November 3, 2010 / 1 Comment

November 1, 2010  source: Gene Security Network (download the pdf press release) REDWOOD CITY, CA – November 1, 2010 – Gene Security Network, Inc. (GSN) today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners. GSN […]

Read More

Fertility Patients Can Now Use One Screening for Multiple Types of Genetic Diseases Before Pregnancy

By Claremont Creek Alerts / August 11, 2010 / 0 Comments

August 10, 2010 source: Send2Press Newswire DAVIS, Calif., Aug. 10 (SEND2PRESS NEWSWIRE) — California IVF: Davis Fertility Center, Inc. (californiaivf.com), working in conjunction with Gene Security Network (genesecurity.net) leads the field in bringing a new test to patients that combines the detection of single-gene genetic disorders with a 24 chromosome screening. Using Gene Security Network’s […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories

Archives